Background/Aims: Circular RNAs (circRNAs) are a class of long noncoding RNAs with a closed loop structure that regulate gene expression as microRNA sponges. CircRNAs are more enriched in brain tissue, but knowledge of the role of circRNAs in temporal lobe epilepsy (TLE) has remained limited. This study is the first to identify the global expression profiles and characteristics of circRNAs in human temporal cortex tissue from TLE patients. Methods: Temporal cortices were collected from 17 TLE patients and 17 non-TLE patients. Total RNA was isolated, and high-throughput sequencing was used to profile the transcriptome of dysregulated circRNAs. Quantitative PCR was performed for the validation of changed circRNAs. Results: In total, 78983 circRNAs, including 15.29% known and 84.71% novel circRNAs, were detected in this study. Intriguingly, 442 circRNAs were differentially expressed between the TLE and non-TLE groups (fold change≥2.0 and FDR≤0.05). Of these circRNAs, 188 were up-regulated, and 254 were down-regulated in the TLE patient group. Eight circRNAs were validated by real-time PCR. Remarkably, circ-EFCAB2 was intensely up-regulated, while circ-DROSHA expression was significantly lower in the TLE group than in the non-TLE group (P<0.05). Bioinformatic analysis revealed that circ-EFCAB2 binds to miR-485-5p to increase the expression level of the ion channel CLCN6, while circ-DROSHA interacts with miR-1252-5p to decrease the expression level of ATP1A2. Conclusions: The dysregulations of circRNAs may reflect the pathogenesis of TLE and circ-EFCAB2 and circ-DROSHA might be potential therapeutic targets and biomarkers in TLE patients.
Introduction
Epilepsy is a common chronic neurological disorder and affects nearly 50 million individuals, representing nearly 0.4-1% of the worldwide population [1] . Cortical neuron abnormalities and synchronous firing may produce seizures [2] . The seizure-prone cortex can transform incoming stimulation into paroxysmal discharges; its excitability is regulated by the ongoing synaptic activity of the intercellular network [3] , but the cellular and molecular mechanisms are not well understood. Temporal lobe epilepsy (TLE) is a common type of epilepsy that is accompanied by pharmacoresistance and requires surgical resection of the epileptic focus [4] . Brain specimens from epileptic patients underwent surgery provide an opportunity to study the mechanisms of pathogenesis and epileptogenesis. Human TLE pathology includes abnormalities in the uncus, amygdala and lateral temporal neocortex [5] , and many of these abnormalities are associated with excitatory ion channels and altered ionotropic receptors [6] [7] [8] [9] . Genome-wide expression profiling has revealed that patterns of ion channels and associated receptor genes are significantly altered in human TLE tissues [10] [11] [12] [13] , but how these genes expression is regulated remains unknown. Examinations of these mechanisms may provide important new insights into epilepsy pathogenesis and yield novel therapeutic targets.
Recent genomic studies have revealed a broad scope of noncoding RNAs (ncRNAs) that are implicated in gene regulation in various diseases. The expression of noncoding RNA is also altered in human epilepsy [14] and may serve as a novel, noninvasive biomarker to improve the current diagnosis of epilepsy [15] . Circular RNAs (circRNAs), a unique class of long noncoding RNAs (lncRNAs) with a stable structure formed by special loop splicing, are novel and critical regulatory RNA molecules [16] [17] [18] [19] [20] . circRNAs interact with microRNAs (miRNAs) and act as a miRNA sponge to regulate gene expression through circRNA-miRNAmessenger RNA (mRNA) axes in neurological diseases [21] . Furthermore, circRNAs are evolutionary conserved and expressed in time-, cell type-and gene-specific manners [19] [20] [21] [22] . While most circRNAs are generally expressed at very low levels, some show cell typespecific and tissue-specific expression with high copy and transcript numbers (>10-fold) [20] [21] [22] . Interestingly, circRNAs are more enriched in brain tissue [23] [24] [25] [26] [27] . In addition, synaptic fractions, including the neuropil and synaptosomes, contain more circRNAs [23] . These findings hint that circRNAs play important roles in neuronal function, especially in synapses [28] . Histological findings have confirmed that synaptic reorganisation of limbic structures appears to progressively enhance cortical hyperexcitability and might contribute to epilepsy onset [29] . However, the roles of circRNAs in epilepsy remain largely unknown. Temporal lobe sclerosis (TLS) is a pathological entity that accompanies TLE; a pathological diagnosis of TLS is defined by a variable reduction in neurons and laminar gliosis in cortical layers II/III [5] . Although TLS is present in only 11% of TLE patients, its pathology reflects typical glial and neuronal abnormalities [5] . TLS is an example of abnormal cortical findings in epilepsy that can serve as an ideal model to study changes in temporal neocortex genes in TLE patients.
In this study, to assess the role of circRNAs in human TLE, we used high-throughput sequencing methods and profiled genome-wide circRNA expression levels in the temporal neocortex of TLE and non-TLE patients. The Ensembl reference system and Database for Annotation, Visualisation, and Integrated Discovery (DAVID) software were used to investigate the functions of dysregulated circRNAs. Bioinformatic filtering for potential target genes included a phenotype-guided approach. We depicted a network containing potential genes correlated with circRNA-miRNA axes.
Materials and Methods

Ethics statement
This study was approved by the Ethics Committee of Beijing Tiantan Hospital, Capital Medical University. All information regarding the human material used in this study was managed using anonymous numerical codes, and samples were handled in compliance with the Declaration of Helsinki.
Patient selection and tissue collection
Drug-resistant TLE patients who were surgical candidates were examined at the Epilepsy Center of Beijing Tiantan Hospital. Full epileptological assessment including sleepless and sleep electroencephalography (EEG) were performed on all the patients. MRI and PET-CT were also conducted on all patients. The site of the epileptogenic area and surgical strategy were discussed with our epilepsy surgery team according to all electroclinical, neuroimaging, and clinical data. Tailored temporal lobe resection was performed on the TLE patients; other surgeries involved the removal of additional brain tissues, such as the temporal pole, anterior neocortical lateral cortex, hippocampus, and parahippocampalgyrus. Non-TLE patients diagnosed with subcortical brain tumours (the distance between the tumour and the cortex exceeded 1 cm on average) underwent lesion and temporal neocortex resection. Intraoperative electrocorticography (I-EEG) was used for both the TLE and non-TLE patients. The TLE neocortex was identified as an epileptogenic area, while the non-TLE neocortex showed negative results. In the surgery operating room, the middle brain section was divided into two parts. One part was instantly placed in RNAlater solution (TIANGEN, Beijing, China) and stored at -80 °C, and the second part was fixed in 4% paraformaldehyde (0.1 M phosphate buffer) for 24 hours at 4 °C [30] . After fixation, the tissue was paraffin embedded and then stored at 4 °C. Fixed specimens were stained with haematoxylin and eosin for histological diagnosis. Histological examination of the fixed control tissue from the non-TLE control group assessed in this study indicated that these tissues were tumour free. Temporal cortices were selected and divided into the following two groups: the non-TLE control group and TLE group.
Immunohistochemistry
Tissue was cut at approximately 1-1.5 cm caudal to the temporal pole. Then, tissue slices were taken at 5 μm. Briefly, tissue slides were deparaffinised, rehydrated and washed; 3% hydrogen peroxide in water was used to quench endogenous peroxidase. Sections were then microwaved with antigen retrieval buffer. Primary antibodies, such as NeuN (Abcam, MA, USA; 1:200) and GFAP (Dako, CA, USA; 1:2000), were incubated with tissue slides overnight at room temperature. Visualisation of the tissue slides was performed using a DAKO Envision horseradish peroxidase kit (Dako, Glostrup, Denmark). To standardize cell staining intensity, we included all slides on a single immunohistochemistry cycle.
RNA isolation and quality control
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, USA) from the different tissues according to the manufacturer's protocol as previously described [31] , and the purity and quantity of RNA were determined using a NanoDrop 2000 (Thermo Fisher Scientific, Wilmington, USA) and a Qubit 3.0 Fluorometer (Life Technologies, Malaysia). A RNA 6000 Nano Chip on a 2100 Bioanalyzer (Agilent, CA, USA) was used to measure RNA integrity number (RIN) values.
RNA library preparation and sequencing
For circRNA library preparation, 1.5 µg of total RNA was ribodepleted using a Ribo-ZeroTM Magnetic Gold Kit (human/mouse/rat) (Epicentre, WI, USA). Ribosomal RNA depletion was assessed by a Bioanalyzer RNA 6000 Pico Chip (Agilent). Ribosomal depletion RNA was treated with 20 U/L RNaseR (Epicentre, WI, USA) for 1 hour at 37 °C. The RNA was immediately purified with RNA Clean XP magnetic beads (Beckman Coulter, CA, USA). Subsequently, circRNA libraries were prepared using an NEB Next Ultra Directional RNA Library Prep Kit (New England Biolabs, Singapore).
Library concentration was assessed by a Qubit 3.0 Fluorometer, and the library size and quantity were detected by a DNA 1000 chip on an Agilent 2100 Bioanalyzer. Then, a qPCR-based KAPA Biosystems Library Quantification Kit (KapaBiosystems, MA, USA) was employed to determine accurate quantification for sequencing applications. Libraries were sequenced on an Illumina HiSeq4000 (Illumina, USA). Raw reads were demultiplexed with default settings to obtain high-quality reads (clean reads) (for all online suppl. material, see www.karger.com/doi/10.1159/000487161, Suppl. Data 1).
circRNA detection and annotation circRNA sequences were predicted using CircRNA Identifier (CIRI) software established by Gao et al. [32] ; CIRI scans Sequence Alignment Map (SAM) files two times and then assembles appropriate information to recognize and illustrate circRNAs. Briefly, junction reads with paired chiastic clipping (PCC) circRNA candidate evaluation by paired-end information Back-splice mapped mates were initially extracted from the paired-end sequencing data of circRNAs and used to evaluate circRNA candidate information. Then, 400-800 nt length fragments of the 5` ends of linear transcripts of circRNAs were copied to the 3` end of these linear transcripts. Tophat 2 was employed to map these mates to modified linear sequences up to 2 mismatches. Percentages of back-splice mates were calculated using Corresponding Mate (PCMM) values. These PCMM values indicate that the back-splice mates could be mapped to the candidate circRNA sequence.
Differential expression analysis
For differential expression analysis of circRNAs, the numbers of reads that spanned a particular headto-tail junction were used as a measurement. Differential expression analysis was determined using the EdgeR package (version3.6.8). The Trimmed Mean of M-values (TMM) normalisation method was used in this package to remove systematic technical effects [33] . The following criteria were used: log2-fold change (log2FC) and FDR were log2FC≥1 and FDR≦0.05.
Function of circRNA predictions
For circRNAs with post-transcriptional regulatory functions that tend to influence overlapping or neighbouring genes, we annotated circRNAs with protein-coding genes (host genes) by splice junctions according to the Ensembl reference system (version GRCh37.75). Then, we analysed the host gene's function to predict circRNA function. Gene Ontology (GO) enrichment analysis was performed using DAVID (http//david.abcc.ncifcrf.gov). All unique circRNA-hosting genes were required to be consistent with the background gene set, and all differentially expressed circRNA-hosting genes (DEG hosting genes) were required to be consistent with the test gene set. Then, the enrichment of GO terms for the circRNAhosting genes was performed. circRNAs targeting miRNAs and genes were theoretically predicted using the TargetScan (Release 7.1) and Miranda (August 2010 Release) databases.
circRNA validation QPCR was performed with the Geneseed® qPCR SYBR® Green Master Mix (Geneseed, Guangzhou, China) using an ABI7500 Real-Time PCR detection system. β-actin RNA was used as a control for the experiment. We designed two sets of primers, including convergent primers that bound to linear 5`-3` mRNA transcripts and divergent primers that bound to the circRNA transcript formed in a 3`-5` fashion; primers were provided by Geneseed Bio Technologies. The real-time PCR cycling conditions were as follows: 95 °C for 5 min, 40 cycles of 95 °C for 15 s, 60 °C for 15 s and 72 °C for 32 s; melting curve analysis occurred from 60.0 °C to 95.0 °C (5 s). All Ct values≥31 were considered background and discarded from further analysis. FCs were calculated using the 2 -ΔΔCt method.
Statistical analysis
Statistical Program for the Social Sciences version 20 (SPSS 20) and GraphPad Prism 6 were simultaneously used. All data were represented as the mean ± standard deviation (SD). Student's t test was used to assess statistical significance, which was considered p<0.05.
Results
Clinical and pathology data
The clinical data of the control and TLE groups are reported in (5-45) and 27.5 (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) in the control and TLE groups, respectively. None of the patients had a history of febrile convulsions or severe brain trauma. All the TLE patients were treated with more than three antiepileptic drugs over two years, but their seizures could not be controlled. I-EEG indicated that the resected cortices of TLE patients had markedly abnormal discharge (Fig. 1a) . Neuropathological examination showed that these patients had temporal lesions and hippocampal sclerosis. The temporal cortex was normal in the control group, but a laminar band of abnormalities in layers II and III (arrowhead) was found in the TLE group (TLS). NeuN staining revealed marked neuronal depletion from cortical layer II to layer III, with GFAP immunostaining showing a band of laminar gliosis (Fig. 1b) .
Temporal cortex circRNA expression profiling in human TLE
High-throughput sequencing facilitated our research on circRNA expression profiles in temporal cortices from the control and TLE groups. Genome-wide sequencing identified 736 million raw reads in both the control and TLE groups (see supplementary material, Suppl. Table 1 ). After excluding low-quality reads, 64.5 million clean reads in the control group and 62.2 million clean reads in the TLE group remained for further analysis. Among these reads, 54.3 million (84.04%) in the control group and 49.5 million (79.51%) in the TLE group were perfectly mapped to the human genome in GenBank (see supplementary material, Suppl. Table 2 ).
A total of 78983 circRNAs were detected in two pairs of our samples. Of these circRNAs, 15.29% were known, while 84.71% were newly detected. Interestingly, 58558 circRNAs were classified as exonic, 10520 were classified as intronic, and the others were classified (Fig. 2a) . The expression levels of different types of circRNAs in our data are shown in Fig. 2b . Known circRNAs were more highly expressed than novel circRNAs. Exonic circRNA expression levels were higher than intronic and intragenic circRNA expression levels in the temporal cortex. The GC content of all circRNAs and exonic circRNAs in our samples was higher than that of those listed in the circRNA database (http://www.circbase. org/), but the GC content of intronic and intergenic circRNAs was similar to that of those 
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Cellular Physiology and Biochemistry in the circRNA database (Fig. 2c) . The peak values of circRNA length content in our data focused on the 558 bp region, while the peak value for circRNAs in the database focused on the 4105 bp region. The length of most exonic circRNA distributions in our data was centred on the lower region (almost less than 500 bp), and the intronic and intergenic distributions were generally consistent with those in the circRNA database. The length content of new and known circRNAs had similar characteristics, indicating that our new circRNA data are reliable (Fig. 2d) . The distributions of circRNAs and genes on human chromosomes are displayed in Fig. 2e . Compared with the genes, the circRNAs were also widely distributed in all chromosomes but had lower distributions on chromosome Y and at centromeres and higher distributions at the two ends of the chromosomal arms on each chromosome.
Analysis of differentially expressed circRNAs
Differentially expressed circRNAs are shown in Fig. 3a , see supplementary material, Suppl. Fig. 1 and Supp. Table 3 . Hierarchical clustering showed differentially expressed circRNAs, with a significant difference between the TLE and control samples. As a result, Table 2 .
To gain insights into our circRNA data, we annotated circRNAs with protein-coding genes (host genes) by splice junctions. The DAVID (DAVID Bioinformatics Resources 6.8) database (https://david.ncifcrf.gov/) was used to analyse circRNA-host gene function to predict circRNA function. We used a cutoff of 0.05 to select the most relevant biological function (Fig.  3b) . GTPase activity pathway was enriched in the highest number of differentially expressed genes. To select functional, differentially expressed circRNAs, we compared the 100 most differentially expressed circRNAs with 5058 functional genes in the GO database (Fig. 3c) . We found 58 common genes between the two groups and selected 10 neurological functions associated with circRNAs as candidates ( Table 3) .
Validation of the differential expression levels of circRNAs
We selected 10 mostly dysregulated circRNAs for validation using real-time PCR in 5 pairs of samples (see supplementary material, Suppl. Tables 4). The primer information of the circRNAs is provided, see supplementary material, in Suppl. Table 5 . Particularly, circ- EFCAB2, circ-VPS37C and circ-STK24 were significantly up-regulated in the TLE group compared with those in the control group, while circ-DROSHA, circ-STK17A, circ-UBQLN1, circ-USP9Y and circ-CCT4 were down-regulated (Fig. 4a) . General consistency was shown between the high-throughput data and real-time PCR results. Further, we chose most upregulated (circ-EFCAB2) and down-regulated circRNAs (circa-DROSHA) for real-time PCR in our 28 clinical samples ( Fig. 4b and see supplementary material, Suppl. Table 6 ). Significant different expressions of these circRNAs can be shown between control groups and TLE groups. Taken together, we found that circ-EFCAB2 and circ-DROSHA were dysregulated in temporal cortex tissue in the TLE patients.
circRNA-miRNA-mRNA network prediction and annotation
To determine the function of circ-EFCAB2 and circ-DROSHA interactions, the TargetScan (http://www.targetscan.org) and Miranda (http://www.microrna.org) databases were used to predict their target miRNAs by conserved seed-matching sequences. miRNA seed sequence matching predicted that the top 5 predicted miRNAs of circ-EFCAB2 were miR-5787, miR-6884-5p, miR-3929, miR-6780a-5p, and miR-4739 and that those of circ-DROSHA were miR-1252-5p, miR-651-3p, miR-4446-5p, miR-548ab, and miR-4762-3p (from high to low). Through target gene prediction, the 10 aforementioned miRNAs and the target genes for each circRNA were collected (Fig. 5) . These RNA interactions could provide a novel perspective of the mechanisms of epilepsy.
Discussion
TLE seizures start in the temporal lobe cortex and exhibit signs of abnormal cortical firing [2] . The most common neuropathological correlate of TLE is hippocampal sclerosis, and only a small TLE patient population has cortical pathological abnormalities. TLS, one type of TLE, is diagnosed by neuronal depletion and gliosis from cortical layer II extending to layer III using NeuN and GFAP immunohistochemistry; thus, TLS provides a perfect model to study cortical epilepsy genetics [5] . In our study, we first analysed the genome-wide circRNA A component of the ESCRT-I complex is associated with cell growth and differentiation and acts as a regulator in vesicular trafficking process [59] .
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Cellular Physiology and Biochemistry profiles in the temporal cortex tissue of TLE patients; a limited number of circRNAs were altered in TLE circRNA profiles, and distinct circRNA changes were observed in the temporal cortices of TLE patients. circRNAs can be from coding and noncoding exons, introns, or both exons and introns [34, 35] . Different types of circRNAs have different locations and functions. A recent study revealed the cytoplasmic location of exonic circRNAs and their high stability in cells [22] . Some exonic circRNAs can interact with miRNAs and/or RNA-binding proteins (RBPs), and many encircle the regions containing the canonical translation start codon [18, 19] . Thus, exonic circRNAs potentially play a regulatory role in gene expression and translation. Intronic circRNAs display more nuclear localisation and fewer conserved sequences than exonic circRNAs [34] . Moreover, intronic circRNAs seems to be less affected, and their expression levels are positively associated with the expression levels of their targeted mRNAs [34] . Exonic-intronic circRNAs have both exonic and intronic circRNA features [35] . Interestingly, 74.14% of our detected circRNAs arise from exons, indicating that most circRNAs in our data correlate with exons and may play regulatory roles in epilepsy.
circRNAs could influence gene transcription, mRNA splicing, RNA decay and translation and could participate in a wide range of biological processes [36] [37] [38] . circRNAs have been associated with neurodegenerative diseases, such as multiple sclerosis, Parkinson's disease, Alzheimer's disease and schizophrenia [18, 39] . In our research, bioinformatics analysis of differentially expressed circRNAs indicated that these circRNAs might be associated with pathways such as GTPase activity, protein transport, and protein phosphorylation; these pathways play key roles in the pathogenesis of epilepsy [40, 41] .
In our study, the expression levels of circ-EFCAB2 and circ-DROSHA were clearly altered in temporal cortex tissue from TLE patients. These two circRNAs arise from exons and may regulate their host genes. The host genes of circ-EFCAB2 and circ-DROSHA are EF-hand calcium-binding domain-containing protein 2 (EFCAB2) and Drosharibonuclease III (DROSHA), respectively. The EFCAB gene family mainly selectively and non-covalently interacts with calcium ions (Ca 2+ ) [42] . Up-regulation of EFCAB2 could influence calcium ion binding and thus could contribute to epilepsy. DROSHA is a double-stranded RNAspecific endoribonuclease that influences the initial step of miRNA biogenesis [43] , the loss 
Cellular Physiology and Biochemistry of which causes neuronal and glial abnormality, seizures, and neurodegenerative disorders [44] . McKiernan and colleagues found that reduced ribonuclease III levels in TLE patients might influence the epileptic phenotype [45] . Our study indicated that circ-EFCAB2 and circ-DROSHA might be involved in the process of TLE by regulating EFCAB2 and DROSHA (Fig. 6) . However, further research is required to study the function of circ-EFCAB2 and circ-DROSHA in TLE models. Bioinformatic analysis predicted that circ-EFCAB2 and circ-DROSHA may function as "miRNAsponges" by regulating genes in the predicted circRNA-miRNA-gene axis. The top 10 predicted target miRNAs were shown in our study, and many were associated with some disorders. In the circ-EFCAB2-targeting miRNA-gene network, miR-485-5p was expected to Cellular Physiology and Biochemistry affect networks of genes that are important in neuronal plasticity and development [46] . Synaptic reorganisation of mossy fibre projections of the TLE hippocampus plays a significant role in persistent cellular hyperexcitability in the epileptic circuitry of the hippocampal formation [29] . Furthermore, the miRNA-targeting gene chloride channel 6 (CLCN6) is a family member of chloride channels (CLCs) associated with a multitude of physiologic processes involved in electrical excitability, transepithelial transport, electroneutrality, and ionic homeostasis [47] ; CLCN6 is also altered in mesial TLE blood samples [48] . In the circ-DROSHA-targeting miRNA network, miR-1252-5p was selected due to the highest scores in this network; its target gene, the alpha 2 subunit of Na + , K + -ATPase (ATP1A2), has a strong relationship with epilepsy [49] . ATP1A2 plays significant roles, including clearing the extracellular K + and preventing the depolarisation of neurons during high neuronal excitability [50] ; ATP1A2 is also a candidate gene for human epilepsy [51] . Since circ-EFCAB2 and circ-DROSHA were predicted as sponges of these miRNAs, they might take in these miRNAs and thus inhibit target gene expression and affectthe pathogenesis of TLE. These circRNAs may help us understand new mechanisms of TLE. However, the validation of these circRNA-miRNA-target gene axes must be further studied in TLE models (Fig. 6 ). This study contributes to our knowledge of the mechanisms that regulate coding and noncoding gene expression in TLE and the changes produced when the temporal cortex is exposed to persistent seizure activity.
Conclusion
In summary, we conducted a comprehensive analysis of circRNA profiles in human temporal cortex tissue from TLE patients. In this report, we identified 8 circRNAs in epilepsy patients and validated these circRNAs using real-time PCR. Moreover, bioinformatic analysis revealed that circ-EFCAB2 and circ-DROSHA might be involved in TLE pathogenesis due to their potential roles in several epilepsy-related miRNAs. Taken together, the results show that circRNAs might be a new cellular mechanism underlying the pharmacological intractability of human TLE.
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